For Quick Alerts
For Daily Alerts

Panacea Biotec Locked In 20% Upper Circuit On Tie Up For Covid 19 Vaccine


Shares in Panacea Biotech in trade on June 10, 2020 were locked in 20% upper circuit after the pharma company informed the stock exchanges that it has tied up with Refana Inc. for a Covid 19 vaccine.

Panacea Biotec Locked In 20% Upper Circuit On Tie Up For Covid 19 Vaccine

As per the agreement, Panacea will engage in the development of the vaccine for global access via a joint venture company with base in Ireland. Sales and distribution activities shall be carried out by both the firms in their respective network.

And further as part of the tie up the company's MD said it aims to manufacture more than 500 million doses of Covid 19 vaccine candidate with more than 40 million doses expected for availability in the next year.

On the BSE, shares of Panacea Biotec were locked at a price of Rs. 202.8, while on the NSE it was locked at Rs. 203.7 shares apiece.

    Read more about: panacea biotec
    Story first published: Wednesday, June 10, 2020, 11:32 [IST]
    Company Search
    Get Instant News Updates
    Notification Settings X
    Time Settings
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more